Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Outline
- Section 1: What are interleukins?
- What are interleukins? (1)
- What are interleukins? (2)
- Section 2: The interleukin-17 family
- The interleukin-17 family (1)
- The interleukin-17 family (2)
- Section 3: Discovery of IL-17A
- Discovery of IL-17A (1)
- Discovery of IL-17A (2)
- Section 4: Biological function of IL-17A
- Biological function of IL-17A (1)
- Biological function of IL-17A (2)
- Biological function of IL-17A (3)
- Biological function of IL-17A (4)
- Biological function of IL-17A (5)
- Biological function of IL-17A (6)
- Biological function of IL-17A (7)
- Biological function of IL-17A (8)
- Section 5: IL-17A producers
- IL-17A producers (1)
- IL-17A producers (2)
- IL-17A producers (3)
- IL-17A producers (4)
- IL-17A producers (5)
- Section 6: Technologies to detect IL-17A
- Technologies to detect IL-17A: ELISA
- Technologies to detect IL-17A: Flow cytometry
- Technologies to detect IL-17A: Cytokine secretion assay
- Technologies to detect IL-17A: Mass cytometry
- Technologies to detect IL-17A: scRNAseq
- Section 7: Targeting IL-17A in inflammatory disease
- Targeting IL-17A in inflammatory disease
- IL-17 and psoriasis (1)
- IL-17 and psoriasis (2)
- IL-17A inhibition in psoriasis
- Targeting the IL-17 axis
- Thank you and acknowledgements
Topics Covered
- What are interleukins?
- The interleukin-17 family
- The discovery of IL-17A
- The biological function of IL-17A
- Cellular producers of IL-17A
- Technologies that are frequently used to detect IL-17A
- The role of IL-17A in inflammatory disease
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Taams, L. (2022, October 31). Interleukin-17: from clone to clinic [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/ORPX3152.Export Citation (RIS)
Publication History
Financial Disclosures
- Past research in the Taams lab has been supported by the following industrial partners: GSK, Novartis Novo Nordisk, Sanofi, UCB.
Other Talks in the Series: The Immune System - Key Concepts and Questions
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, my name is Leonie
Taams and I'm a professor
of Immune Regulation and
Inflammation at King's
College London.
In this seminar,
I will talk about
interleukin-17 from
clone to clinic.
0:16
The outline of this
seminar is as follows:
First, I will briefly explain
what are interleukins.
I will then touch upon the
interleukin-17 family in
general before delving into
more detail on the IL-17A.
I will discuss its
discovery and I
will talk about its
biological function;
the cells that produce
interleukin-17A,
technologies that can
be used to detect,
IL-17A and I will describe how
IL-17A can be targeted
therapeutically in
inflammatory disease.
0:49
To start off with,
what are interleukins?
0:55
Interleukins or ILs in short,
are cytokines which
are small proteins,
usually less than 20 kilodalton.
These molecules
have hormone-like
function which enables cells
to communicate to each other.
Interleukins can bind to
interleukin receptors
on recipient cells to
mediate cytokine signalling.
Cytokines can function
in an autocrine manner,
which means that a
cytokine acts back on
the cell that produces it
or in a paracrine manner,
which means it acts on
a neighboring cell.
Some cytokines can also work in
a distant manner acting on
cells or organs far away
from the site of origin of
the cytokine in a very similar
manner as hormones do.
1:39
Interleukins were
first thought to
be expressed by leukocytes only.
Leukocytes are white blood cells
and this is what
gave it the name.
However, we now know
that interleukins can
be produced by many
other body cells.
Interleukins can play
a central role in
many different
processes that are
important for the well-functioning
of our immune system,
including effects on
immune cell activation,
differentiation, proliferation,
maturation, migration,
or adhesion.
But interleukins can also
influence non-immune
cell function.
For example, it can have
effects on stromal cells,
bone, liver, heart, brain cells,
basically almost
all, if not all,
cells and tissues
of the body can
be influenced by interleukins.